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Abstract
Objectives: Pancreaticoduodenal trauma (PDT) is associated with substantial mortality and morbidity. In
this study, contemporary trends were analysed using national data.
Methods: The Nationwide Inpatient Sample for 1998–2009 was queried for patients with PDT. Interven-
tions including any operation (Any-Op) and pancreas-specific surgery (PSURG) were identified. Trends in
treatment and outcomes were determined [complications, length of stay (LoS), mortality] for the Any-Op,
PSURG and non-operative (Non-Op) groups. Analyses included chi-squared tests, Cochran–Armitage
trend tests and logistic regression.
Results: A total of 27 216 patients (nationally weighted) with PDT were identified. Over time, the
frequency of PDT increased by 8.3%, whereas the proportion of patients submitted to PSURG declined
(from 21.7% to 19.8%; P = 0.0004) and the percentage of patients submitted to non-operative manage-
ment increased (from 56.7% to 59.1%; P = 0.01). In the Non-Op group, mortality decreased from 9.7%
to 8.6% (P < 0.001); morbidity and LoS remained unchanged at ~40% and ~12 days, respectively. In the
PSURG group, mortality remained stable at ~15%, complications increased from 50.2% to 71.8% (P <
0.0001) and LoS remained stable at ~21 days. For all PDT patients, significant independent predictors of
mortality included: the presence of combined pancreatic and duodenal injuries; penetrating trauma, and
age >50 years. Having any operation (Any-Op) was associated with mortality, but PSURG was not a
predictor of death.
Conclusions: The utilization of operations for PDT has declined without affecting mortality, but operative
morbidity increased significantly over the 12 years to 2009. The development of an evidence-based
approach to invasive manoeuvres and an early multidisciplinary approach involving pancreatic surgeons
may improve outcomes in patients with these morbid injuries.
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Introduction
Pancreaticoduodenal trauma (PDT) in the setting of abdominal
trauma is rare, representing 0.5–5.0% of all such traumas.1,2
However, these injuries have historically carried a risk for mortal-
ity ranging from 10% to 40%.1,3–6 Recent expert recommendations
have urged the more conservative management of many intra-
abdominal organ injuries, including PDT.7 The current guidelines
issued by the Eastern Association for the Surgery of Trauma
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recommend non-operative management for Grade I and II inju-
ries, and operation (resection or drainage) for injuries of Grade III
and higher.7
Both operative and non-operative protocols for the manage-
ment of PDTs are among the most challenging clinical scenarios
faced by surgeons. Prior research has focused on rates of mortality
after PDT and thus little is known about the extent of complica-
tions in patients following PDT and whether surgical interven-
tions exacerbate or alleviate the risk for complications.
This project was undertaken to study the changing patterns of
intervention for PDT on a national basis over a period of 12 years,
to investigate patterns of surgical intervention, and to establish
whether new practice patterns have improved mortality and mor-
bidity in patients with PDT.
Materials and methods
Data source
The US Nationwide Inpatient Sample (NIS) was queried for the
12-year period from 1998 to 2009 for all patients with pancreatic
or duodenal trauma. The NIS, a part of the Healthcare Cost and
Utilization Project (HCUP), is a national, all-payer discharge
database containing information on a representative stratified
sample of 20% of non-federal US community hospitals in partici-
pating states, including academic and specialty hospitals.8 The NIS
weighting strategy facilitates the drawing of population-based
estimates at the national level.
Cohort assembly
Patients with PDT were identified if they had been admitted emer-
gently or had a primary ICD-9 CM (International Classification of
Diseases, Revision 9, Clinical Modification)9 diagnosis code for
injury to the pancreas or duodenum (codes 863.21, 863.31,
863.82, 863.84, 863.94. 863.92, 863.81, 863.83, 863.91 and 863.93)
(Table 1). Patient data were then analysed to identify any surgical
intervention (Any-Op), including exploratory laparotomy, small
bowel resections, or pancreas-specific intervention using ICD-9
CM procedure codes 45.01, 45.02, 45.51, 45.6x, 52.13, 51.11, 51.10,
54.19, 54.11, 54.12, 52.52, 52.51, 52.53, 52.59, 52.6, 52.7, 52.95,
88.95 and 52.93. This surgical group was subdivided into two
cohorts according to the presence or absence of pancreas-specific
surgeries (PSURG) using ICD-9 CM procedure codes 52.52,
52.51, 52.53, 52.59, 52.6, 52.7 and 52.95. The non-operative (Non-
Op) group included patients who did not undergo any of the
surgical interventions defined here. Patients were excluded if they
were aged  18 years or  95 years, had been admitted electively
or had an invalid admission type.
Outcomes
The primary outcome measures were rates of surgical interven-
tions in PDT patients over time. Secondary outcomes included
mortality, length of stay (LoS), and the occurrence of major
in-hospital complications, including cardiovascular or deep vein
thrombosis (CV/DVT), gastrointestinal, pulmonary or urinary
complications, infection and myocardial infarction, as defined by
the present authors and others.10–12
Statistical analysis
All analyses were performed using sas Version 9.2 (SAS Institute,
Inc., Cary, NC, USA).13 Univariate analyses were used to compare
differences between subsets of treatment groups and included
chi-squared tests of association for categorical variables. Trend
tests for annual point estimates were performed using the
Cochran–Armitage trend test for binary variables. A linear regres-
sion model was used to determine trends over time for continuous
variables. P-values of < 0.05 were considered to indicate statistical
significance. All data were weighted to nationally representative
numbers using the validated weighting strategies provided by
HCUP.8
Multivariable logistic regression models were constructed with
the occurrence of mortality or a major in-hospital complication as
the dependent variable (outcome). Independent variables with
both statistical significance at the P < 0.05 level on univariate
analyses or clinical relevance (established a priori) were included
in multivariable models; these included race (White, Black, His-
panic, other/missing), age (< 40 years, 40 years), sex, Elixhauser
comorbidity score (0, 1, 2),14 hospital characteristics including
location (urban versus rural), region, size and teaching status, and
type of insurance (Medicare, Medicaid, private, uninsured, other/
missing). Adjusted odds ratios (AORs) were calculated to deter-
mine the effects of the covariates on outcomes of interest.
This study was determined to be exempt from requirements for
ethical approval by the University of Massachusetts Medical
School Institutional Review Board.
Results
Patient and hospital characteristics
During the study period, 27 216 nationally weighted patients with
PDT were admitted. Nearly three-quarters of this cohort (73.6%)
were male. The mean age of the patients was 37.7 years; the mean
Elixhauser score was only 0.8. The majority of patients were
treated at urban (93.1%), large (73.4%) and teaching (74.0%)
hospitals (Table 2). From 1998 to 2009, the number of patients
admitted with PDT increased by 8.3% from 2115 to 2290. Patients
admitted more recently were older at presentation (37 years versus
Table 1 Cohort assembly: definitions used to define injury of the
pancreas and/or duodenum (PDT), and to define any surgical inter-
vention (Any-Op) and pancreas-specific interventions (PSURG)
ICD-9 CM diagnoses and procedure codes
PDT 863.21, 863.31, 863.82, 863.84, 863.94, 863.92,
863.81, 863.83, 863.91, 863.93
Any-Op
Non-PSURG 45.01, 45.02, 45.51, 45.6x, 52.13, 51.11, 51.10,
54.19, 54.11, 54.12, 88.95, 52.93
PSURG 52.52, 52.51, 52.53, 52.59, 52.6, 52.7, 52.95
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40 years; P = 0.0008) and had more comorbidities (mean Elix-
hauser score: 0.5 versus 1.3; P < 0.0001).
Although the rate of isolated pancreatic injury, without concur-
rent duodenal injury, rose over the study period (from 58.2% to
64.2%), fewer isolated duodenal injuries were seen (32.9% versus
27.6%) and the combined injury rate remained stable at ~8%. The
majority of PDT was caused by blunt injury. The mechanism of
injuries changed over the course of the study, with increases in the
proportions of injuries caused by motor vehicle accidents (from
29.9% to 34.0%; P < 0.0001) and falls (from 3.7% to 7.3%; P <
0.0001), and decreases in the proportions caused by penetrating
traumas including stab wounds (from 8.8% to 7.7%) and gunshot
wounds (from 21.2% to 16.7%).
Trends in location of injury
The distribution of pancreatic injuries by location was as follows:
50.5% were reported as affecting multiple locations; 17.3% per-
tained to the head of the pancreas, 9.6% to the pancreatic body,
and 22.6% to the pancreatic tail.
From 1998 to 2009, the proportion of injuries affecting
the head of the pancreas remained stable at ~15% (P = 0.07),
the proportion of injuries to the body of the pancreas
decreased from 11.3% to 8.0% (P = 0.01) and the proportion of
injuries to the tail of the pancreas decreased from 26.3% to
21.2% (P = 0.006). The proportion of patients with multiple
injuries to the pancreas increased from 48.2% to 53.8%
(P = 0.004).
Table 2 Patient and hospital characteristics
Variable All PDT Any-Opa PSURGa Non-Opa
Patients, n 27 216 11 011 5483 16 205
Proportion of all patients, % 100% 40.5% 20.1% 59.5%
Demographics
Age, years, mean 37.7 35.7 35.9 39.0
Male, % 73.6% 79.5% 80.5% 69.7%
Race, %
White 38.6% 33.5% 33.8% 42.1%
Black 19.3% 23.1% 24.0% 16.6%
Hispanic 12.3% 13.3% 13.8% 11.5%
Other/unknown 29.8% 30.0% 28.4% 29.7%
Mean Elixhauser comorbidity score, %
0 51.6% 51.3% 51.7% 51.8%
1 27.2% 28.0% 28.1% 26.6%
 2 21.2% 20.6% 20.3% 21.6%
Trauma type, %
Pancreas alone 58.1% 65.0% 88.3% 53.4%
Duodenum alone 33.5% 23.8% – 40.1%
Combined pancreas + duodenum 8.4% 11.2% 11.7% 6.5%
Hospital type, %
Urban 93.1% 95.7% 95.5% 91.3%
Teaching 74.0% 79.3% 78.3% 70.5%
Hospital bed size, %
Small 4.2% 3.3% 3.2% 4.9%
Medium 22.3% 22.2% 23.5% 22.3%
Large 73.5% 74.5% 73.4% 72.8%
Primary insurance, %
Medicare 6.5% 5.6% 6.2% 7.1%
Medicaid 17.1% 21.0% 19.8% 14.4%
Private 39.7% 33.8% 32.5% 43.8%
Uninsured 23.9% 25.9% 27.5% 22.6%
Other/missing data 12.7% 13.6% 13.9% 12.1%
aThe Any-Op group includes patients who underwent any abdominal operation; the PSURG group includes patients who underwent a pancreas-
specific operation; the Non-Op group includes patients who were managed non-operatively.
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Trends in interventions
Across the entire cohort, 11 011 patients (40.5%) were submitted
to surgery (Any-Op group) and 16 205 patients (59.5%) were
managed non-operatively (Non-Op group). A total of 5483
patients (20.1%) underwent pancreas-specific surgery only
(PSURG group). Fewer than 50% of operating room interventions
warranted any pancreatic surgery. Only 1.5% of patients required
endoscopic intervention (endoscopic retrograde cholangiopan-
creatography or stent placement).
Overall, within the PSURG group, 1976 patients (36.0%)
underwent a primary repair procedure, 2681 (48.9%) underwent
distal pancreatectomy, 162 (3.0%) underwent total pancreatec-
tomy, 165 (3.0%) underwent radical pancreaticoduodenectomy or
radical pancreatectomy, and 499 (9.1%) underwent partial or
proximal pancreatectomy. Further analysis for trends referred to
the collapsed PSURG group, rather than specific surgery types, as
a result of NIS reporting requirements.
Because of the small sample numbers, data for patients treated
with endoscopic procedures during 1998–2003 and 2004–2009,
respectively, were collapsed to enable a comparison. The rate of
endoscopic intervention did not change (~1.5%; P = 0.9).
From 1998 to 2009, the proportion of patients managed non-
operatively increased from 56.7% to 59.1% (P = 0.01). The overall
rate of Any-Op declined (from 43.3% to 40.9%; P = 0.01), as did
the utilization of PSURG (from 21.7% to 19.8%; P = 0.0004).
Trends in short-term outcomes
Over the 12-year period of study, outcomes in patients with PDT
improved. Mortality decreased from 12.7% to 11.0% (P <
0.0.001). Most of this decrease reflects a drop in mortality in the
Non-Op group, from 9.7% to 8.6% (P < 0.0001). Mortality in the
Any-Op group did not change significantly (16.9% versus 12.9%;
P = 0.2) (Fig. 1).
A total of 46.6% of patients across the entire PDT cohort expe-
rienced major complications.
The most common complications were pulmonary compro-
mise and infectious complications (Table 3). Patients who under-
went an operation (Any-Op group) had increasingly higher rates
of complications. This was especially significant in the PSURG
group, among which the rate of complications increased from
50.2% to 71.8% (P < 0.0001). However, in the Non-Op group, the
rate of complications was unchanged (40.8% versus 35.4%; P =
0.5). Similar trends were seen for LoS, which increased from 16.6
days to 21.5 days (P = 0.007) in the Any-Op group, and from 19.1
days to 22.9 days (P = 0.0001) in the PSURG group. In the
Non-Op group, LoS remained stable (12.3 days versus 11.7 days;
P = 0.3).
Predictors of complications and mortality
Multivariable logistic regression models were created to identify
predictors of complications and mortality among patients with
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Figure 1 (a) Mortality and (b) morbidity in an extrapolated sample of 27 216 patients admitted for injury to the pancreas and/or duodenum
during 1998–2009 by intervention type. Non-Op, non-operative group; PSURG, pancreas-specific surgery group
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PDT. After controlling for demographic and clinical variables,
significant independent predictors of mortality for all PDT
patients included: combined pancreaticoduodenal injury; pen-
etrating trauma mechanism; age >40 years, and being uninsured.
Having any surgery (Any-Op group) was associated with mortal-
ity, but PSURG was not a predictor of death (Table 4).
After controlling for demographic and clinical variables, signifi-
cant predictors of complications included: penetrating trauma;
combined pancreaticoduodenal injury; receipt of operation; age
>40 years; a greater number of comorbidities, and having Medic-
aid insurance (Table 4).
Discussion
This study of recent national trends in the operative management
of PDT found increasing rates of non-surgical management and
improvements in overall mortality, but persistently high morbid-
ity. Although the rate of complications in the Non-Op group
remained unchanged, the rate of complications in the PSURG
group rose by >20%. To the present authors’ knowledge, this is the
first study to examine national trends and outcomes in PDT over
the last decade.
Historically, mortality for PDT has been as high as 40% because
the condition is often associated with multi-organ injury.5,15 More
recently, in a retrospective examination of data from 11 trauma
centres, Velmahos et al. found overall mortality of 11.7% and
reported that the operative group fared slightly less well (15%)
than the group managed conservatively (7%).6 In a single-
institution study, Antonacci et al. noted 22% mortality.5 The
present study, which analysed national data for a 12-year period,
showed that the improvement in mortality occurred across the
country, not just in individual high-volume trauma centres that
had previously reported their outcomes.
When the results are stratified by intervention, the majority of
the improvement in mortality is seen to be associated with non-
operative management; there is no significant change in rates of
mortality among patients undergoing surgery. Furthermore, a
more detailed look at associated rates of complications shows a
significant rise in morbidity associated with operative manage-
ment, whereas outcomes in non-operatively managed patients
remained unchanged. Some of these findings can be attributed to
selection bias because the most severe cases of injury will require
an operation. One possible explanation refers to the more wide-
spread availability of angioembolization, which allows the non-
operative management of some types of abdominal bleeding
(spleen, renal, etc.) that in the past would have warranted abdomi-
nal surgery. This creates a new subset of patients in whom
exploratory surgery is performed. Another possible explanation
refers to the greater availability of better rescue therapies, as a
result of which patients who in the past would have died, now
survive, but have a prolonged recovery course with complications.
Finally, some of the increase in complication rates can be attrib-
uted to a national recognition system and improvements in
recording and reporting the occurrence of complications.
However, there appears to be an inconsistent association between
mortality and morbidity which suggests that other factors may
contribute to this increase in the rate of complications. Further
investigation of this subject is warranted.
Pancreaticoduodenal trauma patients are a very heterogeneous
group. As injuries in recent years have tended to reflect blunt
trauma, and seatbelt laws have become more stringent, the higher
morbidity may be associated with a shift in the type of pancreatic
injury, which cannot be quantified using a national database.
Pancreatic surgery is a technically complex procedure, even
when performed by experienced pancreatic surgeons. Birkmeyer
et al. showed that operative mortality in complex operations was
Table 3 Major postoperative in-hospital complications and in-hospital mortality after pancreaticoduodenal trauma. Data refer to the
Nationwide Inpatient Sample (NIS) for 1998–2009
Complication Overall weighted n Total Any-Op a PSURG a Non-Op a
Patients in group, n 27 216 27 216 11 011 5483 16 205
Complications 12 672 46.6% 59.6% 59.8% 37.7%
Postoperative infection 3 507 12.9% 16.8% 17.7% 10.2%
Myocardial infarction 103 0.4% b b 0.34%
Aspiration pneumonia 267 1.0% 1.0% b 1.0%
DVT/PE 656 2.4% 3.5% 4.0% 1.7%
Pulmonary compromise 5 460 20.1% 27.3% 26.9% 15.1%
Gastrointestinal haemorrhage 816 3.0% 4.6% 5.5% 1.9%
Reopening surgical site 1 453 5.3% 12.6% 7.9% b
Perforation/laceration 7 037 25.9% 32.9% 35.3% 21.1%
Mortality 3 122 11.5% 14.5% 12.6% 9.5%
aThe Any-Op group includes patients who underwent any abdominal operation; the PSURG group includes patients who underwent a pancreas-
specific operation; the Non-Op group includes patients who were managed non-operatively.
bData cannot be reported because of small cell numbers; agreements on the use of NIS data preclude the use of cells containing < 10 patients.
DVT, deep vein thrombosis; PE, pulmonary embolism.
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inversely proportional to individual surgeon volume, with the
greatest difference noted in pancreatic surgery.16 In 2007, the
present group showed that operations performed by surgeons
who had carried out at least 60 pancreatic cancer surgeries as
attending surgeons were associated with significant decreases in
operating room time and intra-operative blood loss, a higher
percentage of margin-negative resections, and a shorter associated
LoS.17 Pancreatic trauma is rare and is seen in only 0.5–5% of
trauma cases, even at a Level I trauma centre. In addition, a large
proportion of patients with pancreatic injury are managed non-
operatively. In particular patients in whom pancreas-directed
surgery, especially pancreatic resection, may be under considera-
tion, the involvement of a dedicated pancreaticobiliary surgeon in
the decision-making process may be helpful to the multidiscipli-
nary team.
This study has several important limitations. The NIS is an
administrative database and lacks certain clinical variables, includ-
ing patient-level factors, such as injury severity score, imaging,
laboratory values, operative data (blood loss, transfusions, opera-
tive time), and longterm follow-up and readmission information.
Major postoperative complications were assessed using a validated
set of ICD-9 codes; however, complication rates can be underesti-
mated because individual medical records cannot be reviewed, and
the NIS does not include complications that occur after the
patient’s discharge. Insufficient coding specifications in the NIS
precluded the accurate assessment of the important complications
of biliary stricture, duct injury, leak or fistula because the use of
ICD-9 codes to evaluate bile duct injuries has been demonstrated
to substantially underestimate their true incidence.18,19 The data-
base also does not allow for the assessment of perioperative vari-
ables that influence the surgeon’s decision to take the patient to the
operating room, which results in some selection bias.
Despite these limitations, this is the first national study to
examine contemporary operative interventions for PDT, and to
Table 4 Multivariable logistic regressions: adjusted odds ratios for mortality and morbidity during hospitalization for pancreaticoduodenal
trauma
Predictors of in-hospital
mortality
OR (95% CI)
Predictors of in-hospital
complications
OR (95% CI)
Age  40 years (versus < 40 years) 2.13 (1.75–2.59) 0.94 (0.82–1.07)
Male (versus female) 1.19 (0.94–1.51) 1.37 (1.18–1.59)
Race
Black (versus White) 1.05 (0.84–1.33) 1.20 (1.00–1.45)
Hispanic (versus White) 1.10 (0.82–1.47) 1.15 (0.96–1.37)
Other/unknown (versus White) 1.25 (1.01–1.55) 1.02 (0.88–1.18)
Elixhauser comorbidity score
1 (versus 0) 0.87 (0.70–1.08) 1.32 (1.14–1.54)
 2 (versus 0) 0.62 (0.49–0.78) 1.89 (1.60–2.23)
Injury mechanism penetrating versus blunt 1.68 (1.31–2.16) 2.80 (2.36–3.34)
Unknown versus blunt 1.24 (1.0–1.55) 1.93 (1.66–2.25)
Injury type
Duodenum alone versus pancreas 0.81 (0.66–0.99) 1.54 (1.34–1.77)
Pancreas + duodenum versus pancreas 1.66 (1.27–2.17) 1.77 (1.43–2.19)
Interventions
Surgery versus no surgery 1.75 (1.42–2.16) 1.90 (1.60–2.25)
PD surgery versus no surgery 0.63 (0.48–0.82) 1.20 (0.99–1.45)
Hospital location
Urban (versus rural) 2.46 (1.62–3.76) 2.22 (1.67–2.96)
Hospital bed size
Medium (versus small) 1.56 (0.91–2.68) 1.46 (1.09–1.94)
Large (versus small) 1.62 (0.49–0.78) 1.81 (1.39–2.36)
Insurance
Medicare versus private 1.79 (1.30–2.47) 1.17 (0.91–1.50)
Medicaid versus private 1.10 (0.82–1.48) 1.48 (1.24–1.76)
No insurance/self-pay versus private 1.48 (1.20–1.82) 0.91 (0.78–1.07)
Other/missing versus private 0.62 (0.42–0.91) 0.98 (0.81–1.18)
OR, odds ratio; 95% CI, 95% confidence interval; PD, pancreaticoduodenal.
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both analyse mortality and comprehensively examine morbidity
associated with PDT and its treatment. As PDT is rare, the use of
a national database allows for a robust multivariable analysis that
adjusts for the effect of multiple clinical and demographic vari-
ables in a manner that is not possible using a single-institution
database.
Conclusions
During 1998–2009, the utilization of surgery for PDT declined,
along with a minor decrease in mortality associated with non-
operative management. However, in patients who underwent
surgery, mortality was unchanged and the rate of complications
increased significantly. The outcomes of PDT are impacted by
many factors. An evidence-based approach to invasive manoeu-
vres and a multidisciplinary approach that enables the early
involvement of team members with expertise in trauma and pan-
creatic surgery, interventional radiology and gastroenterology
may improve outcomes in these morbid and costly injuries.
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